Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-053218

Chief Financial Officer sold 60,000 shares at an average $74.15 ($4,448,762)

  • Chief Financial Officer acquired 60,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GARCIA PETER S · Chief Financial Officer

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-23 Exercise or conversion : show line 1 in the form +60,000 $4.08 $244,800 69,331 D
2021-08-23 Sale : show line 2 in the form −1,593 $70.86 $112,872 67,738 D
2021-08-23 Sale : show line 3 in the form −3,497 $72.03 $251,906 64,241 D
2021-08-23 Sale : show line 4 in the form −18,060 $72.66 $1,312,252 46,181 D
2021-08-23 Sale : show line 5 in the form −4,008 $73.57 $294,871 42,173 D
2021-08-23 Sale : show line 6 in the form −19,448 $75.09 $1,460,278 22,725 D
2021-08-23 Sale : show line 7 in the form −10,743 $75.71 $813,317 11,982 D
2021-08-23 Sale : show line 8 in the form −2,616 $76.66 $200,550 9,366 D
2021-08-23 Sale : show line 9 in the form −35 $77.56 $2,715 9,331 D
Open-market sales · 60,000 sh · avg $74.15 · $4,448,762

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-08-23 Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) −40,630 95,659 D
2021-08-23 Exercise or conversion : show line 11 in the form Employee Stock Option (right to buy) −19,370 80,468 D
Loading xslF345X03/doc4.xml…